Results 301 to 310 of about 159,964 (350)
Some of the next articles are maybe not open access.

Pitfalls, challenges, and updates in adjuvant systemic treatment for resected biliary tract cancer

Expert Review of Gastroenterology & Hepatology, 2021
Introduction: Unfortunately, potentially curative surgical resection is possible in approximately the 25% of biliary tract cancer (BTC) patients at diagnosis, and even following radical surgery, relapse rates remain high.
A. Rizzo, G. Brandi
semanticscholar   +1 more source

Biliary tract cancer

Current Opinion in Gastroenterology, 1995
Biliary tract cancer is a rare cancer in most parts of the world, but it is relatively common in some countries and ethnic groups, such as Japan, Central and South America, eastern Europe and in American Indians, and Hispanics. In some countries, such as Japan, Sweden, Finland and Italy, the age adjusted mortality of biliary tract cancer has been ...
Jean-Nicolas Vauthey, Paul Dudrick
openaire   +3 more sources

Molecular Characterization of Biliary Tract Cancer Predicts Chemotherapy and Programmed Death 1/Programmed Death‐Ligand 1 Blockade Responses

Hepatology, 2021
Biliary tract cancer (BTC) exhibits diverse molecular characteristics. However, reliable biomarkers that predict therapeutic responses are yet to be discovered.
Jihoon G. Yoon   +12 more
semanticscholar   +1 more source

Biliary Tract Cancer

2006
AbstractThis chapter reviews the epidemiology of biliary tract cancer. Many etiologic leads for biliary tract cancer have come from clinical observations, autopsy series, and descriptive epidemiologic studies. While a significant fraction of these tumors are related to gallstones (cholelithiasis), information on other risk factors is limited, due to ...
ANN W. HSING   +3 more
openaire   +1 more source

Conversion surgery for initially unresectable locally advanced biliary tract cancer: A multicenter collaborative study conducted in Japan and Korea

Journal of hepato-biliary-pancreatic sciences
Although surgical resection is the only curative treatment for biliary tract cancer, in some cases, the disease is diagnosed as unresectable at initial presentation. There are few reports of conversion surgery after the initial treatment for unresectable
Y. Yabushita   +28 more
semanticscholar   +1 more source

Gemcitabine and Oxaliplatin Chemotherapy or Surveillance in Resected Biliary Tract Cancer (PRODIGE 12-ACCORD 18-UNICANCER GI): A Randomized Phase III Study.

Journal of Clinical Oncology, 2019
PURPOSE No standard adjuvant treatment currently is recommended in localized biliary tract cancer (BTC) after surgical resection. We aimed to assess whether gemcitabine and oxaliplatin chemotherapy (GEMOX) would increase relapse-free survival (RFS) while
J. Edeline   +23 more
semanticscholar   +1 more source

[Biliary tract carcinomas. II. Biliary tract cancer].

Vutreshni bolesti, 1982
The authors discuss the biliary tract carcinoma in the second paper on biliary tract carcinomas. It ranks second as regards frequency, being responsible for 4 per cent of the biliary operations. The analysis is based on 48 observations during the period 1952-1979 at the Chair of Abdominal Surgery - 31 males and 17 females (2:1).
A, Merdzhanov   +3 more
openaire   +1 more source

[Biliary tract cancers].

La Revue du praticien, 2001
Biliary tract cancer is the second most common primary hepatobiliary cancer, after hepatocellular carcinoma. The most frequent localisation is the gallbladder. Mean age of diagnosis is 65 years. The exact cause remains unknown despite well documented risk factors. The majority of these tumours are adenocarcinomas. Symptoms, frequently non specific, are
E, Yahchouchi, D, Cherqui
openaire   +1 more source

Radiotherapy for Biliary Tract Cancers

Seminars in Radiation Oncology, 2018
Biliary tract cancers (BTCs), including intrahepatic, perihilar and distal cholangiocarcinomas, and gallbladder cancers, are a heterogeneous cohort of tumors that tend to present with advanced stage and with high rates of recurrence after surgical resection.
Florence K, Keane   +2 more
openaire   +2 more sources

Biliary Tract Cancer

2017
Biliary tract cancers encompass tumors of the gallbladder, extrahepatic bile ducts, and ampulla of Vater. In the United States, biliary tract cancer is the fifth most common malignant neoplasm of the digestive tract, accounting for about 3,700 deaths per year.
Jill Koshiol   +4 more
openaire   +1 more source

Home - About - Disclaimer - Privacy